Awarded
2ª Prorroga (adelantada) Suministro de NATALIZUMAB jeringa (TYSABRI) y DIROXIMEL FUMARATO cápsula (VUMERITY) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid Original language: Spanish
Contract value €325,570
Bids received 1
Published 4 Aug 2025
Awarded 30 Jul 2025
Contract start 30 Jul 2025
Contract end 16 Aug 2026estimated More awards from this buyer Awarded Buyer Winner Contract value Published ATOGEPANT (AQUIPTA 60 mg comprimidos 28 comprimidos) HOSPITAL CLINICO SAN CARLOS ABBVIE SPAIN, S.L €243,588 28 Oct 2026 ATOGEPANT (AQUIPTA 10 mg comprimidos 28 comprimidos) HOSPITAL CLINICO SAN CARLOS ABBVIE SPAIN, S.L €12,991 28 Oct 2026 FILSPARI 400 MG COMPRIMIDOS 30 comprimidos HOSPITAL CLINICO SAN CARLOS VIFOR PHARMA ESPAÑA S.L. €253,394 28 Oct 2026 FILSPARI 200 MG COMPRIMIDOS 30 comprimidos HOSPITAL CLINICO SAN CARLOS VIFOR PHARMA ESPAÑA S.L. €9,704 28 Oct 2026 2ª prorroga RINGER LACTADO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICO HOSPITAL CLINICO SAN CARLOS FRESENIUS KABI ESPAÑA, S.A. €17,390 23 Oct 2026 2ª prorroga GLUCOSALINO SOLUCIÓN ESTÉRIL Y APRIRÓGENA EN AGUA PARA INYECCIÓN ADMINISTRACIÓN IV FRASCO PLÁSTICO SEMIRRÍGIDO O BOLSA PLASTICO HOSPITAL CLINICO SAN CARLOS FRESENIUS KABI ESPAÑA, S.A. €4,880 23 Oct 2026
See HOSPITAL CLINICO SAN CARLOS's next tender before it is published.
Adjudera alerts you to public contracts expiring in your sector — with the current supplier and the contract value. Cancel monthly, 7-day money-back guarantee.